Hospital acquired infections are one of the biggest problems facing global healthcare
Millions of patients catch infections from their hospital stay every year, prolonging the time they spend in hospital and costing many of them their lives.
These infections cost healthcare systems around the world billions in unplanned care, increased medication and congested waiting lists.
The biggest cause of these infections are urinary catheters used during inpatient treatment. Read more >
A step change in preventing catheter related HAIs
Unlike current coating technology, Camstent’s coating doesn’t attempt to kill bacteria but creates a 'non-stick' surface that resists bacteria colonisation.
By preventing bacteria from attaching to the catheters used during treatment, biofilm development is inhibited, protecting patients from infection.
The coating is applied to standard Foley catheters during manufacture, making it a cost-effective solution to a significant healthcare problem. Read more >
Camstent’s coating is uniquely bacteria-phobic
Our technology employs amphiphilic molecules that can be polymerised over surfaces as monolayer coatings that resist blood and protein attachment. This process enables catheters to be created that inhibit bacterial biofilm formation without killing microorganisms.
The Camstent bacteria-phobic coating does not contribute to bacterial resistance, requires no delivery system, and remains intact and effective throughout normal use of the catheter. Read more >
"I feel we have an exciting opportunity to make a real difference in tackling hospital-acquired infections. Our coating acts as a non-stick surface for bacteria and is a fundamental technology advance in preventing Catheter Associated Urinary Tracts Infections (CAUTIs)."
Dr Dave Hampton, Chief Technical Officer